Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 864,772
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

Cybin Inc., doing business as Helus Pharma, a clinical stage pharmaceutical company, focuses on developing therapies to treat various psychiatric and neurological conditions.It develops HLP003, a deuterated psilocybin analog, which is in phase 3 clinical trial to treat major depressive disorder (MDD); and HLP004, a deuterated N, N-dimethyltryptamine (DMT), which is in phase 2 clinical trial for treating generalized anxiety disorders. The company' preclinical product includes HLP005, a phenethyla...

Industry: Biotechnology
Sector: Healthcare
Phone: 908 764 8385
Address:
100 King Street West, Suite 5600, Toronto, Canada
Buckwacker
Buckwacker Aug. 31 at 9:10 AM
$HELP I’ve never shorted a stock, why would you bet on/ try and harm a company that is dedicated to making a difference?? Bears you have tons of ass hole companies that deserve your attention this is not one of them You’re not scoring
0 · Reply
RuddyRolls
RuddyRolls Aug. 31 at 12:48 AM
$HELP 🔥
0 · Reply
RuddyRolls
RuddyRolls Aug. 31 at 12:41 AM
$HELP Just because you feel the vibe .. 😂 https://x.com/one_hardTruth/status/2093541398784160096
0 · Reply
RuddyRolls
RuddyRolls Aug. 31 at 12:37 AM
$HELP The SpaceX rare stable genius doesn't even include the known known of the impact of the data drop in it its projection - despite observing Oct 16 "data window approaching". Outliers could easily be $3 and $60 after data drop. Such weak at looking around corners - even ones that have mirrors installed. If only The Intelligence had some wetware we could augment with The Product. ;) https://x.com/one_hardTruth/status/2093541398784160096
0 · Reply
Solomonwisdom7
Solomonwisdom7 Aug. 29 at 8:29 PM
$HELP chatGTP predictive SP forecast for next 6 weeks. Mark this post as it will be interesting to confirm how accurate it is: Week ending Most likely range Sep 4 $10.75–$13.50 Sep 11 $10.50–$14.00 Sep 18 $10.75–$15.00 Sep 25 $11.00–$16.00 Oct 2 $10.75–$17.00 Oct 9 $10.00–$18.00
2 · Reply
Solomonwisdom7
Solomonwisdom7 Aug. 29 at 7:05 PM
$HELP You like that movie Don’t you! 😂
0 · Reply
Sailingsoon
Sailingsoon Aug. 29 at 6:07 AM
$HELP This was an 19k up and down week just with Help and Compass alone Anyone an idea ?
0 · Reply
leLu83
leLu83 Aug. 29 at 1:17 AM
$HELP you guys should buy the "dip" 🤣🤣🤣
1 · Reply
RuddyRolls
RuddyRolls Aug. 29 at 12:23 AM
$HELP $CMPS "The FDA and Health and Human Services are requesting public input on psychedelic provider training and credentialing, patient safety, access, data collection, and standardization. A hearing is scheduled for September 14, and people can submit written comments through October 5." https://www.federalregister.gov/documents/2026/07/14/2026-14155/considerations-for-potential-future-therapeutic-use-of-psychedelic-drugs-public-hearing-request-for https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/considerations-potential-future-therapeutic-use-psychedelic-drugs-public-hearing-09142026?utm_source=substack&utm_medium=email
0 · Reply
RuddyRolls
RuddyRolls Aug. 28 at 11:31 PM
$HELP Help is available. 😂
0 · Reply
Latest News on HELP
Helus Pharma price target raised to $62 from $8 at TD Cowen

2026-08-20T11:40:59.000Z - 10 days ago

Helus Pharma price target raised to $62 from $8 at TD Cowen


Helus Pharma appoints Regina Donohue as chief people officer

2026-08-18T11:35:22.000Z - 12 days ago

Helus Pharma appoints Regina Donohue as chief people officer


Cybin Earnings release: Q1 2027

Aug 14, 2026, 4:00 PM EDT - 16 days ago

Cybin Earnings release: Q1 2027


Helus Pharma appoints Michael Halstead as CEO

2026-08-05T14:38:41.000Z - 25 days ago

Helus Pharma appoints Michael Halstead as CEO


Helus Pharma initiated with an Overweight at Wells Fargo

2026-07-27T09:20:12.000Z - 5 weeks ago

Helus Pharma initiated with an Overweight at Wells Fargo


Helus Pharma price target lowered to $42 from $45 at Canaccord

2026-07-01T10:40:45.000Z - 2 months ago

Helus Pharma price target lowered to $42 from $45 at Canaccord


Cybin Annual report: Q4 2026

Jun 29, 2026, 7:00 AM EDT - 2 months ago

Cybin Annual report: Q4 2026


Cybin Earnings release: Q4 2026

Jun 29, 2026, 7:00 AM EDT - 2 months ago

Cybin Earnings release: Q4 2026


Cybin Slides: Corporate presentation

Jun 29, 2026, 7:00 AM EDT - 2 months ago

Cybin Slides: Corporate presentation


Helus Pharma™ Announces US$50 Million Underwritten Offering

Jun 24, 2026, 6:01 AM EDT - 2 months ago

Helus Pharma™ Announces US$50 Million Underwritten Offering


Cybin Transcript: Jefferies Global Healthcare Conference 2026

Jun 4, 2026, 2:35 PM EDT - 3 months ago

Cybin Transcript: Jefferies Global Healthcare Conference 2026


Cybin Slides: Corporate presentation

Mar 27, 2026, 8:00 AM EDT - 5 months ago

Cybin Slides: Corporate presentation


Cybin Transcript: Study result

Mar 5, 2026, 7:30 AM EST - 6 months ago

Cybin Transcript: Study result


Cybin Press release: Study result

Mar 5, 2026, 7:30 AM EST - 6 months ago

Cybin Press release: Study result


Cybin Slides: Study result

Mar 5, 2026, 7:30 AM EST - 6 months ago

Cybin Slides: Study result


Cybin Earnings release: Q3 2026

Feb 13, 2026, 12:30 PM EST - 7 months ago

Cybin Earnings release: Q3 2026


Cybin Registration statement: Registration Filing

Dec 19, 2025, 7:00 AM EST - 9 months ago

Cybin Registration statement: Registration Filing


Cybin to Transfer U.S. Stock Exchange Listing to Nasdaq

Dec 18, 2025, 12:29 PM EST - 9 months ago

Cybin to Transfer U.S. Stock Exchange Listing to Nasdaq


Cybin Transcript: Jefferies London Healthcare Conference 2025

Nov 17, 2025, 7:30 AM EST - 10 months ago

Cybin Transcript: Jefferies London Healthcare Conference 2025


Cybin Earnings Call Transcript: Q2 2026

Nov 13, 2025, 8:00 AM EST - 10 months ago

Cybin Earnings Call Transcript: Q2 2026


Cybin Earnings release: Q2 2026

Nov 13, 2025, 8:00 AM EST - 10 months ago

Cybin Earnings release: Q2 2026


Cybin Transcript: Future of Health Summit 2025

Nov 5, 2025, 2:00 PM EST - 10 months ago

Cybin Transcript: Future of Health Summit 2025


Cybin Announces Closing of $175 Million Registered Direct Offering

Oct 31, 2025, 4:19 PM EDT - 10 months ago

Cybin Announces Closing of $175 Million Registered Direct Offering


Cybin Announces $175 Million Registered Direct Offering

Oct 28, 2025, 8:00 AM EDT - 10 months ago

Cybin Announces $175 Million Registered Direct Offering


BetterLife Pharma Appoints Doug Drysdale as Corporate Advisor

Oct 21, 2025, 8:00 AM EDT - 11 months ago

BetterLife Pharma Appoints Doug Drysdale as Corporate Advisor


Cybin Registration statement: Registration Filing

Sep 17, 2025, 8:00 AM EDT - 1 year ago

Cybin Registration statement: Registration Filing


Cybin Transcript: Cantor Global Healthcare Conference 2025

Sep 5, 2025, 10:20 AM EDT - 1 year ago

Cybin Transcript: Cantor Global Healthcare Conference 2025


Cybin Announces Senior Leadership Changes

Sep 2, 2025, 7:30 AM EDT - 1 year ago

Cybin Announces Senior Leadership Changes


Cybin Announces Results of Annual Meeting of Shareholders

Aug 18, 2025, 5:30 PM EDT - 1 year ago

Cybin Announces Results of Annual Meeting of Shareholders


Cybin Transcript: AGM 2025

Aug 18, 2025, 10:00 AM EDT - 1 year ago

Cybin Transcript: AGM 2025


Cybin Earnings release: Q1 2026

Aug 13, 2025, 4:00 PM EDT - 1 year ago

Cybin Earnings release: Q1 2026


Cybin Registration statement: Registration Filing

Jul 31, 2025, 8:00 AM EDT - 1 year ago

Cybin Registration statement: Registration Filing


Buckwacker
Buckwacker Aug. 31 at 9:10 AM
$HELP I’ve never shorted a stock, why would you bet on/ try and harm a company that is dedicated to making a difference?? Bears you have tons of ass hole companies that deserve your attention this is not one of them You’re not scoring
0 · Reply
RuddyRolls
RuddyRolls Aug. 31 at 12:48 AM
$HELP 🔥
0 · Reply
RuddyRolls
RuddyRolls Aug. 31 at 12:41 AM
$HELP Just because you feel the vibe .. 😂 https://x.com/one_hardTruth/status/2093541398784160096
0 · Reply
RuddyRolls
RuddyRolls Aug. 31 at 12:37 AM
$HELP The SpaceX rare stable genius doesn't even include the known known of the impact of the data drop in it its projection - despite observing Oct 16 "data window approaching". Outliers could easily be $3 and $60 after data drop. Such weak at looking around corners - even ones that have mirrors installed. If only The Intelligence had some wetware we could augment with The Product. ;) https://x.com/one_hardTruth/status/2093541398784160096
0 · Reply
Solomonwisdom7
Solomonwisdom7 Aug. 29 at 8:29 PM
$HELP chatGTP predictive SP forecast for next 6 weeks. Mark this post as it will be interesting to confirm how accurate it is: Week ending Most likely range Sep 4 $10.75–$13.50 Sep 11 $10.50–$14.00 Sep 18 $10.75–$15.00 Sep 25 $11.00–$16.00 Oct 2 $10.75–$17.00 Oct 9 $10.00–$18.00
2 · Reply
Solomonwisdom7
Solomonwisdom7 Aug. 29 at 7:05 PM
$HELP You like that movie Don’t you! 😂
0 · Reply
Sailingsoon
Sailingsoon Aug. 29 at 6:07 AM
$HELP This was an 19k up and down week just with Help and Compass alone Anyone an idea ?
0 · Reply
leLu83
leLu83 Aug. 29 at 1:17 AM
$HELP you guys should buy the "dip" 🤣🤣🤣
1 · Reply
RuddyRolls
RuddyRolls Aug. 29 at 12:23 AM
$HELP $CMPS "The FDA and Health and Human Services are requesting public input on psychedelic provider training and credentialing, patient safety, access, data collection, and standardization. A hearing is scheduled for September 14, and people can submit written comments through October 5." https://www.federalregister.gov/documents/2026/07/14/2026-14155/considerations-for-potential-future-therapeutic-use-of-psychedelic-drugs-public-hearing-request-for https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/considerations-potential-future-therapeutic-use-psychedelic-drugs-public-hearing-09142026?utm_source=substack&utm_medium=email
0 · Reply
RuddyRolls
RuddyRolls Aug. 28 at 11:31 PM
$HELP Help is available. 😂
0 · Reply
BRITLS
BRITLS Aug. 28 at 10:53 PM
$HELP bought back a little of what I sold the last week for. 12% discount but still expect a little more of a drop to pick up the rest.
1 · Reply
Solomonwisdom7
Solomonwisdom7 Aug. 28 at 10:47 PM
$HELP chatGTP Release estimate for Topline HLP003 results: Helus has not given a specific month or date yet; its official guidance remains Q4 2026 (October–December). As of August 28, 2026, that means the readout could plausibly come at any point over the next ~4 months. My best estimate, based on the trial timeline, would be October–November 2026, but that's an inference—not a company-confirmed date.
1 · Reply
RuddyRolls
RuddyRolls Aug. 28 at 10:10 PM
$HELP mark it
0 · Reply
RuddyRolls
RuddyRolls Aug. 28 at 9:28 PM
$HELP I can see this getting violent in the coming weeks as market makers position for an early data drop. Can land very soon as a previous post here points out - data for phase 3 will be in hand now or shortly. So I suspect them to send it up quite substantially to protect themselves. A far higher base in the share price will be preferable to them. At present options are far far too cheap. The relative probability of a $30-$50 post data demands it. Carpe Diem.
0 · Reply
GeorgeJetson17
GeorgeJetson17 Aug. 28 at 7:03 PM
$HELP $CMPS When there's an epic run, people say they'd buy if the stock drops -- well the stock is dropping, so now is your chance. I bought 5,100 more shares of HELP today and I'm glad for the dip.
4 · Reply
Solomonwisdom7
Solomonwisdom7 Aug. 28 at 5:12 PM
$HELP That would seem to make sense
1 · Reply
Sailingsoon
Sailingsoon Aug. 28 at 5:11 PM
$HELP https://www.nature.com/articles/s41586-026-10910-z
2 · Reply
Horseman23
Horseman23 Aug. 28 at 4:40 PM
$HELP sale price!
0 · Reply
Solomonwisdom7
Solomonwisdom7 Aug. 28 at 4:20 PM
$HELP plus we all have to keep in mind that the big run up in share price the past few weeks is based on news about placing a new CEO and not news of positive earnings and profits. The share price becomes anchored in its price after FDA approval and there are earnings to strongly base the share price.
1 · Reply
TalesfromtheF
TalesfromtheF Aug. 28 at 4:00 PM
$HELP Here we go again.
0 · Reply
kev90123
kev90123 Aug. 28 at 3:59 PM
$HELP Someone just sold out
0 · Reply
putINwork
putINwork Aug. 28 at 3:52 PM
$HELP I think they dilute after the price jumps post phase 3 trial results
2 · Reply